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GENE THERAPY IN BIOMEDICINE:
ETHICAL DILEMMAS
KENT THORNBURG AND MILES EDWARDS
INTRODUCTION
Biomedical research is moving so rapidly its progress is breathtak-ing. Yet despite its promise, it carries a host of ethical problems
that have never before been faced in human history. Should we
patent human genes? Should we study human embryos to learn the
roots of gene defects? Should we alter genes to make our offspring
healthier, prettier, smarter, or longer lived? Would Quaker perspec-
tives cast unique insight into these questions? These ethical quan-
daries are complex and strain the limits of human wisdom. In this
article we first offer scientific historical underpinnings of many of the
most acute ethical dilemmas in biomedicine and then we raise sever-
al key queries on which we particularly seek divine instruction.
To many people, World War II is the key event marker of the mid-
twentieth century. Those who personally recall World War II will also
remember how different health care was some 50 years ago.
Antibiotics were discovered just before the war began. Until then, it
was common for apparently healthy people to become ill and die
from infectious diseases like scarlet fever, tuberculosis, poliomyelitis,
and “simple” infections, often within days or weeks of becoming
infected. During the post-war economic boom, experts began to talk
of sparing the human race from the ravages of infectious disease as
new antibiotics and vaccines were being discovered and life expectan-
cy increased. Scientific discovery has brought anesthetics, antibiotics,
cardiac catheterization and bypass technologies, organ transplanta-
tion, and the comforting proton inhibitors (that prevent overacidifi-
cation of the stomach). In 50 years we have come to expect to be
cured of bacterial infections without missing work. Yet, while public
expectations are high, many people may not realize that medical care
is likely to change more in substance and scope in the upcoming few
decades than in all of human history. Beyond the traditional discov-
eries, a new type of medical treatment is about to irreversibly alter the
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nature of clinical medicine as the embryonic stages of a great molec-
ular biology revolution emerge with the turn of the millennium. 
Over the last two decades, the term molecular biology has come to
have a specific meaning. It now refers, not to the study of biological
molecules in general (as it once did), but to the molecules that carry
the genetic code of living organisms, deoxyribonucleic acid (DNA)
and ribonucleic acid (RNA). Molecular biology is the study and use
of genetic molecules and it is the use of these molecules that will alter,
most profoundly, the way medicine will be practiced in the future. A
historical overview is necessary to appreciate the scope of the ethical
dilemmas raised by the molecular biology revolution.
THE NATURE OF THE GENE
At about the turn of the last century, the monk-scientist Gregor
Mendel carried out experiments on the determination of pea color
and other traits that laid the foundation for modern genetics. He
showed that peas have heritable color traits that appear in the next
generation as either dominant or recessive. He showed that these
traits are carried by reproductive cells from one generation to the next
via heritable units, now called “genes.” Soon after World War II,
Watson & Crick (1953) reported the double helix structure of the
DNA molecule and explained how it might replicate. From there, it
did not take long for scientists to make the connection between the
chemical message encoded in every DNA molecule to the true mean-
ing of a gene. 
It is now known that virtually every cell in the body contains com-
plete copies of all 46 human chromosomes. Chromosomes are com-
posed of long twisted strands of DNA that encode all the genetic
information that makes human beings unique as individuals. Since the
discovery of the DNA code, the gene has been carefully defined as a
region on a chromosomal DNA strand that carries the code for a sin-
gle protein. When properly signaled, a cell can manufacture that pro-
tein by reading the gene’s DNA code. To fathom how genes, which
simply carry codes for proteins, can be the basis for fashioning a com-
plex living, breathing, emotion-laden human being, it helps to know
that biological creatures are formed on a complex, but central, pro-
tein master plan. 
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There are several classes of coded proteins that are essential fea-
tures of living organisms. These include: 1) Structural proteins. These
proteins are manufactured for use as structural building blocks. For
example, hair and fingernails are made of a structural protein called
keratin. 2) Enzymes. Proteins in this class regulate all the chemical
reactions of the body. Enzyme names are easily recognizable because
they usually end with an “-ase” suffix. Thus, for example, a lipase is
an enzyme that promotes the breakdown of lipid (fat). 3) Gene
switches. Gene switches are proteins with the sole purpose of binding
DNA to either turn a gene “on” (cause it to begin the process of
making a protein) or to switch the gene “off.” Such switch proteins
are known to scientists as transcription factors. 
A technological tool that makes molecular biology research go
faster is the DNA synthesizer. When a scientist wants to study a piece
of DNA with a known code sequence, she or he can order it from any
laboratory that has a synthesizer. Therefore, once a gene code is
known, the gene itself could be manufactured artificially. Thus it is
theoretically possible (while being wholly impractical) to manufacture
all known genes “from scratch.”
GENE CLONING
The word clone has several different but related meanings. In the gene
world, to clone a gene means to remove the gene-DNA from an
organism’s chromosome and insert it into foreign DNA. Gene
cloning has been possible since 1973 when Cohen and Boyer received
the Nobel Prize for splicing a common bacterial gene. This became
possible because of the discovery of special enzymes in bacteria
(restriction enzymes) that are able to cut DNA at specific sites. These
enzymes are used on DNA as a paring knife is used on a long
sausage—you can cut out the piece you want and glue the cut ends
back together. A piece of gene-coding DNA can be excised from an
animal’s DNA and inserted into bacterial or viral DNA (using anoth-
er set of enzymes) and the original piece of DNA can then be repro-
duced at will by growing and harvesting the bacteria. This is called
gene cloning. A cloned gene can be easily studied and/or re-inserted
into the DNA strand of another organism. Such experiments are now
so easily done and are so commonplace that most high school science
classes include simple cloning experiments as part of their standard
curriculum.
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With this brief background we can address several difficult ethical
issues that have arisen as biotechnology has given us new capabilities
in gene manipulation.
SHOULD WE ALTER THE HUMAN GENE EXPRESSION TO
EXTEND LIFE-SPAN?
Upon the discovery of gene switches, it was immediately apparent to
developmental biologists that such switches could help explain the
nature of the biological “clock.” It appears that from the moment of
conception, a chain of chemical events is set into motion that leads to
the division of the fertilized egg, the development of the embryo,
fetus, child, and adult over time. The biological clock, then, deter-
mines the timing of life’s biological events, birth, puberty, maturity,
aging, and death. The clock has its own inherent rate, though envi-
ronmental factors may affect rate also. This chain of developmental
events begins when a few master gene switches turn on and touch off
a complex chain reaction where each successive set of genes turns on
its own new set. As this highly regulated cascade begins, the biologi-
cal clock starts “ticking.” Studies on lower invertebrate organisms
indicate that a few select genes are able to alter the rate of the clock.
Changing the expression of these genes may severely affect life span—
in the case of a roundworm, by more than doubling it. The intricate
details of the human clock will eventually become understood and
clock-rate (determines rate of aging) will then become alterable
should we choose to do so.
SHOULD WE PATENT NORMAL AND MANUFACTURED
HUMAN GENES?
The DNA code for a protein is determined by the spatial order in
which chemical groups called nucleotides (sometimes called bases)
occur on a DNA molecule. These groups come in four varieties, A, T,
C, G. Within a gene, every three nucleotides code for one amino acid.
For example, AAA is the DNA code for the amino acid called lysine.
A protein is merely a string of different amino acids. When a gene is
“turned on” to make a protein, the code on the DNA for that pro-
tein is sent to the cell’s “protein factory” via another molecule known
as messenger RNA. Thus the code for any gene that is turned on can
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be found by chemically determining the sequence of nucleotides of its
DNA or messenger RNA. Through incredible technological advances
it is now possible for scientists to determine the coding sequence for
long pieces of DNA using a DNA sequencing apparatus. Thus, it is
now possible to rapidly determine the sequence of new genes as they
are discovered. In fact, it is the goal of the scientific community to
find the code for all human genes within the next year or so as part
of the “Human Genome Project.” Because it is estimated that there
are some 150,000 genes in the human genome (the sum total of all
human genes) and each gene may contain thousands of nucleotides,
the human genome project is an enormous undertaking. 
The Human Genome Project is largely funded by the National
Institutes of Health (NIH) with great financial and labor assistance
from many countries. The Project is coding many important research
mammals. Similar projects are under way for some plants as well
because of the obvious agricultural application. Because gene
sequences are patentable, there is great financial reward for a discov-
ered gene. Nowadays, virtually all research institutions get property
rights on new genes and many private and public institutions depend
on income from these patents to fuel further research and develop-
ment. For NIH supported gene discoveries, the code must be put
into a master computer database (a “gene bank”) so that all scientists
have access to the code information. Recently, private companies have
indicated great interest in sequencing large numbers of human gene
fragments for the purpose of claiming rights to those sequences,
should the gene become commercially important. A couple of com-
panies have expressed claims that they can determine code more
quickly than is commonly done in most NIH laboratories and they
plan to win the “race” to control the patents on the many yet undis-
covered genes. This raises questions about private companies holding
large quantities of genetic information that would not necessarily be
made public. This might make research more expensive for all scien-
tists because companies could require royalties on DNA sequences
needed for research products. Proponents of patenting genes argue
that patenting brings energy and capital to the research that is
required to move the field rapidly forward. Without it, decades will
pass before we find cures for common genetic disease.
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SHOULD PERSONAL DNA SEQUENCES BE PRIVATE
INFORMATION?
An important technology that rarely hits the popular press is the
“DNA Chip.” The DNA chip is like a tiny computer chip that binds
specific pieces of DNA. With special probes that turn color, the chips
can be used to screen human or animal DNA and indicate identity.
The technology has a powerful future because it allows rapid DNA
screening for research and medical purposes. It will soon be possible
to do mass screening of human DNA samples to check for virtually all
known gene defects. It may be possible someday to use this technol-
ogy to detect propensities for alcoholism, mental disease, and certain
forms of cancer, to name a few uses. However, people carrying genes
that predispose to disease may be at risk for losing their insurance cov-
erage or worse, new types of group discrimination based on certain
genetic typing could arise.
SHOULD WE STUDY LIVING HUMAN EMBRYOS?
Artificial reproduction technology (ART) has grown enormously in
the past two decades and continues to be an area of intense research
that is fraught with ethical difficulties. In vitro (in the dish) fertiliza-
tion is a commonly used technique in human medicine, in animal
research, and in animal husbandry. Sperm from any donor can be
placed in a dish with mature eggs and the eggs fertilized. Human fer-
tilized eggs (zygotes) can then be allowed to grow to early embryo
stages whereupon the healthy-looking embryos can be placed back
into the uterus of the donor or into a surrogate mother after manip-
ulating the hormonal environment to ensure that the uterus (womb)
is receptive. One of the early obstacles to the success of this technique
was the acquisition of human eggs from the ovary. Most problems
with egg harvesting have now been solved and it is possible to obtain
several eggs, using fiber-optic endoscopy, from ovaries that have been
hormonally primed. Test tube babies were once front page news but
are now commonplace. In fact, countless thousands of women have
been able to overcome reproductive failure through the use of these
techniques. The treatment of reproductive problems is a lucrative
medical business even though the pregnancy success rate at some cen-
ters remains quite low.
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In addition to egg harvesting, there are several crucial advances
that have led to improved success in artificial reproduction.
Cryopreservation, one of the most important, is the “ultra-cold” stor-
age of sperm, eggs, and embryos in liquid nitrogen. This technique
allows the storage of semen, eggs, and embryos for extended periods
of time, some argue, indefinitely. This technology has led to many
new ways of thinking about reproduction. People have chosen to
store their reproductive cells for later use. It has been argued that
women, whose eggs are most fit during their twenties, should pre-
serve their eggs in their prime and then become sterile. This would
allow complete separation of reproductive and sexual activities. The
technology also provides opportunity for men to store semen for the
same purpose or in the case of the Nobel Laureate Sperm Bank, for
preserving highly sought after semen for commercial purposes.
The study of living human embryos is illegal in the United States.
In some countries, human embryos can be studied for a week or so
after fertilization. The embryos must then be destroyed. In the U.S.
alone there are thousands of frozen human embryos in storage wait-
ing to be implanted. In many clinical cases, more embryos are fertil-
ized than are needed to ensure a pregnancy, but the number is not
known in advance. 
The issue of studying human embryos in culture is controversial.
Undoubtedly, if human embryos were to be used for experimenta-
tion, they would die in the process. This raises the question of
whether a human life has been extinguished.
A recent finding complicates matters further. Scientists have found
that embryonic cells in a later (bastocyst) stage are also important
because they can be used as “stem cells.” These embryonic stem cells
(ESC) are the cells that segregate in the early embryo to make the
fetal body (as opposed to the placenta). Animal and human ESC have
been grown in artificial media this year. The culture of human ESC
was funded by a private company (Geron Inc).
This breakthrough is scientifically important because ESCs can be
simulated to become virtually any type of cell in the body and they
can replicate in a dish. This gives hope that new brain, heart, and pan-
creas cells can be made for injection into individuals who are suffer-
ing for having too few functional cells in any such organ. However,
the stem cells must come from a human embryo that will be
destroyed in the process, thus it is not legal to use federal dollars for
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such research. Because these cells can theoretically propagate indefi-
nitely, it is possible that cells from a single human embryo could pro-
vide medical help for many people.
SHOULD HUMANS BE CLONED?
Up to the time the human embryo has divided some three times to
the eight cell stage, each embryo cell is able to be detached from the
others and form a new independent individual. Thus, at the eight cell
stage, it is theoretically possible for the cells to be separated and a
mother could bear genetically identical octuplets from a single
embryo—and each new embryo could be divided at the eight cell
stage to repeat the process. This cell “potency” has been used to
advantage in animal husbandry to glean a large number of genetical-
ly identical offspring from a prize breeding pair.
Any of these early embryonic cells (early blastomeres) could be
used to clone a human being. If a nucleus, say, from a skin cell (which
like other body cells contains all 46 chromosomes) were to be fused
with a human egg to replace the normal egg nucleus and the new
“egg” was stimulated to divide and grow when placed in the womb,
a human clone would be formed. The clone would have the same
genetic makeup as the donor, like an identical twin. Cloning has been
accomplished in sheep (“Dolly”) and in mice but not yet in humans.
It is therefore theoretically possible for a woman to give birth to her
or her father’s (or anyone else’s) “identical twin.” While some argue
that we have no problem with normal identical twins, so we should
not object to making one, others argue that the unnatural circum-
stance would place a cloned “twin” at psychosocial risk. Recently, one
scientist has announced his intention to produce the first human
clone.
SHOULD WE ALTER HUMAN GENES TO CURE GENETIC
DISEASE?
The use of DNA to “cure” medical problems is now a possibility and
medical scientists around the globe are contemplating novel ways to
alter genes as new forms of therapy. The most common way that is
being attempted is called “gene therapy.” Gene therapy is the deliv-
ery of gene products to increase or otherwise alter the manufacture
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of a protein by cells that are involved in a disease process. For exam-
ple, the disease cystic fibrosis (CF) is the most common lethal genet-
ic disease in the United States. In this disease, a protein that moves
chloride into or out of a cell is improperly made by the cell because
its gene code has an error in it—a gene defect. Chloride is the major
ingredient in table salt along with sodium and is important in a host
of physiological processes including water balance. People who have
cystic fibrosis cannot regulate chloride properly and one serious out-
come is that they cannot make the lining of the lung wet enough. The
lining of the lung requires a wet mucus layer to trap bacteria so that
they can be moved out of the airways. Because of this deficiency, CF
patients often die of lung infections before their 30s. Gene therapy is
being tried in these patients by delivering normal copies of the CF
gene to the lung cells via modified cold viruses and having patients
inhale the virus so it can infect their lungs cells and insert the normal
gene. This form of therapy has mixed reviews so far. Even in those for
whom there is relief of symptoms, the effect is not long lasting
because the cells lining the lungs are normally replaced every few
weeks. 
Nevertheless, gene therapy offers hope to a whole host of diseases.
As new delivery viruses (vectors) are being engineered it is hoped that
certain types can be made to infect only selected cells or to be turned
on only in selected cells. Genes can then be delivered to cancer cells,
heart cells, brain cells, or pancreas cells as needed to combat specific
diseases. Some medical experts predict that delivering gene products
to alter disease processes will be the predominant form of medical
therapy in the future.
SHOULD WE CHANGE GENES IN THE GERM LINE?
This question carries the most serious consequences for the human
race. Germ line therapy is different from “ordinary” gene therapy.
Germ line therapy is the alteration of the “germ line,” the DNA that
will be sent to offspring for generations to come. With ordinary gene
therapy, changing the gene expression of the cells lining the lung will
not affect the offspring of the CF patient. However, if we were to
“fix” the CF gene in the fertilized egg, the offspring would be born
without the disease and the faulty gene would be eradicated from the
germ line forever. Germ line therapy is not condoned anywhere in the
Western world at present. However, it is within the power of present
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technology. Once commonplace, could we not then alter other gene
complexes, like those that code for intelligence, muscular strength, or
life span?
CONTEMPLATING THE FUTURE
Now is the time to contemplate where rapid advances in technology
will lead. For the first time in history, human beings will be able rapid-
ly to alter the gene pool of the flora and fauna of the earth. The argu-
ment that selective breeding has been doing the same thing for
centuries does not fairly represent the scale on which it is now possi-
ble to alter genes of plants and animals.
People who suffer from crippling disease may enjoy cures never
before possible in human history. Evolutionists make the point that a
manipulated genome prevents the laws of nature from protecting
only those who are most biologically fit. Christians point to the dan-
gers of mankind altering what God has created and losing respect for
human life. We Quakers, who have provided conscience to the world
on human issues for three centuries, now have opportunities to cast
the light of Christ into the dark ethical corners of biomedicine.
UPDATE SINCE ARTICLE WAS WRITTEN
1. The magazine Science (Mar. 19, 1999) reports that the National
Human Genome Research Institute plans to complete the “first
draft” of the human genome project (coding human genes) by next
spring. The NIH institute awarded some $80 million to finish the
project within the year 2000.
2. There is recent evidence that the offspring of “Dolly” the sheep
(the first cloned mammal) show signs of premature aging of their
DNA. Thus, the clone’s offspring may be more susceptible than nor-
mal to diseases of aging (like cancer and heart disease). This indicates
another potential danger for human cloning.
3. The National Institutes of Health is reviewing its policy toward uti-
lizing human stem cells for research. A Working Group has been
established to advise the NIH Director, Harold Varmus, on the mat-
ter. Advice will be sought by the Group from the National Bioethics
Advisory Commission, the public, and the Congress. A decision
34 • KENT THORNBURG AND MILES EDWARDS
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could be forthcoming by late summer, 1999. If approved, products
for human therapy may be available within a few years time.
RESPONSE 
PHIL SMITH
Iwelcome the opportunity to comment on issues raised by Kent andMiles in their article on gene therapy. For reasons of space, my
comments will be succinct, but I hope not superficial.
Medical science has always combined description and prescription.
It’s not just about discovering the facts, but about using knowledge
to better human life, and wise use is at least as difficult a thing as dis-
covery. The coming molecular biology revolution in medicine under-
scores our need for practical wisdom.
Some people will say all genetic therapy (or all germ line therapy)
is wrong, since it’s not natural. In practice some will endorse (though
they may not say so explicitly) all genetic therapies, or at least all those
for which people are willing to pay. Both of these answers are too sim-
ple. The division between natural and unnatural doesn’t show the line
between right and wrong, neither does consumer preference as regis-
tered in a free market.
We have to ask: What is the human good? What is God’s inten-
tion for human beings? How can medicine serve the human good and
God’s intention? We can’t just “read off” the answers to such ques-
tions from what we are or from what the geneticist is able to do. Our
answers will be shaped by the story, God’s story, in which we find
ourselves.
God intends for people to be “good.” (An Aristotelian would say
“happy” and mean the same thing.) God intends that we be creative,
loving, beautiful, healthy, generous, cooperative, intelligent, etc. The
list of partial descriptors for “good” must be very long. 
Medicine serves the human good in at least four ways, by: 1) pro-
moting life, 2) reducing suffering, 3) removing impediments to other
goods, and 4) enhancing quality of life. Medicine can frustrate God’s
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intention for human flourishing when it is used to a) destroy life, b)
increase suffering, or c) increase invidious social inequality.
Medical interventions can have mixed results. A ventilator can be
used to extend life, but sometimes that use increases suffering.
Practical wisdom is needed to judge whether a particular interven-
tion—genetic therapies included—serves some purposes of medicine
without violating others. A genetic test may benefit a person greatly
by allowing her to prepare ahead of time for some chronic disease,
but that test information should not be used to create invidious
inequality, by barring her from opportunity or from insurance, for
example.
Germ line therapy will require special thoughtfulness. To a greater
degree than past medical interventions, germ line therapy aspires to
improve the quality of human life. But in seeking to make life better
for some (our genetically improved descendants), germ line therapy
also runs greater risks of creating invidious social inequality than past
medical interventions. Germ line therapies must be judged not only
by the promise they offer to the people thus created, but by the
effects of the therapies on those whose parents can’t afford to procure
them.
God in Christ calls us into a kingdom where everyone is valued
and where we share each other’s burdens. Medicine is becoming an
ever more powerful tool for these ends. We have to think, pray, and
hold up to the light of Christ the practical questions Kent Thornburg
and Miles Edwards have posed for us.
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